143 related articles for article (PubMed ID: 12079640)
1. Cardiomyocyte apoptosis after antiviral WIN 54954 treatment in murine coxsackievirus B3 myocarditis.
Kytö V; Saraste A; Fohlman J; Ilbäck NG; Harvala H; Vuorinen T; Hyypiä T
Scand Cardiovasc J; 2002 May; 36(3):187-92. PubMed ID: 12079640
[TBL] [Abstract][Full Text] [Related]
2. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3 induces apoptosis in the early phase of murine myocarditis: a comparative analysis of cardiovirulent and noncardiovirulent strains.
Joo CH; Hong HN; Kim EO; Im JO; Yoon SY; Ye JS; Moon MS; Kim D; Lee H; Kim YK
Intervirology; 2003; 46(3):135-40. PubMed ID: 12867750
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Histone Deacetylase Activity Aggravates Coxsackievirus B3-Induced Myocarditis by Promoting Viral Replication and Myocardial Apoptosis.
Zhou L; He X; Gao B; Xiong S
J Virol; 2015 Oct; 89(20):10512-23. PubMed ID: 26269170
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte apoptosis in experimental coxsackievirus B3 myocarditis.
Saraste A; Arola A; Vuorinen T; Kytö V; Kallajoki M; Pulkki K; Voipio-Pulkki LM; Hyypiä T
Cardiovasc Pathol; 2003; 12(5):255-62. PubMed ID: 14507574
[TBL] [Abstract][Full Text] [Related]
7. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the acute defence reaction by eplerenone prevents cardiac disease progression in viral myocarditis.
Tschöpe C; Van Linthout S; Jäger S; Arndt R; Trippel T; Müller I; Elsanhoury A; Rutschow S; Anker SD; Schultheiss HP; Pauschinger M; Spillmann F; Pappritz K
ESC Heart Fail; 2020 Oct; 7(5):2838-2852. PubMed ID: 32662949
[TBL] [Abstract][Full Text] [Related]
9. Antiviral treatment with WIN 54 954 reduces mortality in murine coxsackievirus B3 myocarditis.
Fohlman J; Pauksen K; Hyypiä T; Eggertsen G; Ehrnst A; Ilbäck NG; Friman G
Circulation; 1996 Nov; 94(9):2254-9. PubMed ID: 8901680
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of coxsackievirus B3 3C protease inhibitor in experimental murine myocarditis.
Yun SH; Lee WG; Kim YC; Ju ES; Lim BK; Choi JO; Kim DK; Jeon ES
J Infect Dis; 2012 Feb; 205(3):491-7. PubMed ID: 22207647
[TBL] [Abstract][Full Text] [Related]
11. [The mechanisms responsible for the therapeutic effects of anti-Fas ligand antibody on viral myocarditis in mice].
Chang H; Han B; Han XZ
Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):920-4. PubMed ID: 16412356
[TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cell-derived cardiomyocytes as an in vitro model for coxsackievirus B3-induced myocarditis and antiviral drug screening platform.
Sharma A; Marceau C; Hamaguchi R; Burridge PW; Rajarajan K; Churko JM; Wu H; Sallam KI; Matsa E; Sturzu AC; Che Y; Ebert A; Diecke S; Liang P; Red-Horse K; Carette JE; Wu SM; Wu JC
Circ Res; 2014 Aug; 115(6):556-66. PubMed ID: 25015077
[TBL] [Abstract][Full Text] [Related]
13. Effects of levosimendan in experimental acute coxsackievirus myocarditis.
Latva-Hirvelä J; Kytö V; Saraste A; Vuorinen T; Levijoki J; Saukko P
Eur J Clin Invest; 2009 Oct; 39(10):876-82. PubMed ID: 19772522
[TBL] [Abstract][Full Text] [Related]
14. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
15. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
16. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
17. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
18. Therapy of coxsackie virus B3-induced myocarditis with WIN 54954 in different formulations.
Pauksen K; Ilbäck NG; Friman G; Fohlman J
Scand J Infect Dis Suppl; 1993; 88():125-30. PubMed ID: 8390715
[TBL] [Abstract][Full Text] [Related]
19.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
20. Crocetin Exerts a Cardio-protective Effect on Mice with Coxsackievirus B3-induced Acute Viral Myocarditis.
Qin L; Liu H; Wang J; Wang W; Zhang L
J Oleo Sci; 2021; 70(8):1115-1124. PubMed ID: 34349088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
